Nico Erhard, Fabian Bahlke, Lovis Spitzauer, Florian Englert, Miruna Popa, Felix Bourier, Tilko Reents, Carsten Lennerz, Hannah Kraft, Susanne Maurer, Alexander Tunsch-Martinez, Jan Syväri, Madeleine Tydecks, Marta Telishevska, Sarah Lengauer, Gabrielle Hessling, Isabel Deisenhofer, Marc Kottmaier
BACKGROUND: Data regarding uninterrupted oral anticoagulation in patients with chronic kidney disease (CKD) during catheter ablation for left atrial arrhythmias is limited. This study aimed to evaluate the safety and efficacy of periprocedural uninterrupted direct oral anticoagulants (DOAC) compared with uninterrupted phenprocoumon in patients with CKD undergoing left atrial catheter ablation. METHODS AND RESULTS: We conducted a retrospective single-center study of patients who underwent left atrial catheter ablation between 2016 and 2019 with underlying chronic kidney disease (glomerular filtration rate (GFR) between 15 and 45 ml/min)...
January 23, 2024: Clinical Research in Cardiology: Official Journal of the German Cardiac Society